Adult
Aged
Antineoplastic Agents/*therapeutic use
*Chemotherapy, Adjuvant
Clinical Trials as Topic
Confidence Intervals
Disease-Free Survival
Female
Follow-Up Studies
Humans
Interferon-alpha/*therapeutic use
Lymphatic Metastasis
Male
Melanoma/*drug therapy/mortality/pathology
Middle Aged
Neoplasm Staging
Prognosis
Proportional Hazards Models
Recombinant Proteins
Retrospective Studies
Survival Analysis
Time Factors
Treatment Outcome
